Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Transfusion|September 1, 1992
Removal of Yersinia enterocolitica from AS-1 red cellsD H Buchholz, J P AuBuchon, E L Snyder, et al.
Transfusion|October 1, 1994
Effects of white cell reduction on the resistance of blood components to bacterial multiplicationD H Buchholz, J P AuBuchon, E L Snyder, et al.
Transfusion|July 18, 2008
The effects of additive solution pH and metabolic rejuvenation on anaerobic storage of red cellsTatsuro Yoshida, James P AuBuchon, Larry J Dumont, et al.
Transfusion|October 12, 2002
Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion studyLarry J Dumont, James P AuBuchon, Pamela Whitley, et al.
The Annals of Thoracic Surgery|January 1, 1994
Cost-effectiveness of preoperative autologous donation in coronary artery bypass graftingJ D Birkmeyer, J P AuBuchon, B Littenberg, et al.
Vox Sanguinis|February 27, 2004
Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United StatesD A Marshall, S H Kleinman, J B Wong, et al.
Vox Sanguinis|April 16, 2002
Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesiumH Gulliksson, J P AuBuchon, M Vesterinen, et al.
Transfusion|December 2, 2000
Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group OM S Kruskall, J P AuBuchon, K Y Anthony, et al.
Transfusion|August 30, 2007
Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping plateletsLarry J Dumont, Hans Gulliksson, Pieter F van der Meer, et al.
Transfusion|March 16, 2002
Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical studyJames P AuBuchon, Constance A Pickard, Louise H Herschel, et al.
Pageof 11